The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Quaternary structure of the specific p53–DNA complex reveals the mechanism of p53 mutant dominance
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The observation that NTAD41, NLS, and CTD resonances are narrow in spectra of full-length p53 and are shifted only slightly from their chemical shifts in isolated peptides is inconsistent with an oligomerization model proposed on the basis of low-resolution (13.7 Å) cryo-electron microscopy data, in which the TET adopts a radically different structure compared to its isolated state and forms st”
From Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR (2022) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 3×
“The structure of the p53 core domain bound to a specific DNA explained the target-specific mechanism of DNA recognition by p53 (9).”
BackgroundInfluentialWhen mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
How p53 binds DNA as a tetramer
McLure, K. G., & Lee, P. W. K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3342 · Cited by 260
Birch, J. M., Blair, V., Kelsey, A. M., Evans, D. G., Harris, M., Tricker, K. J., & Varley, J. M. (1998) · Oncogene · doi:10.1038/sj.onc.1202033 · Cited by 200
Research works printed but not linked: 54
- Vogelstein, 2000, Surfing the p53 network, Nature, 408, 307, 10.1038/35042675 · DOI · Paper page
- Oren, 2003, Decision making by p53: life, death and cancer, Cell Death Differ., 10, 431, 10.1038/sj.cdd.4401183 · DOI · Paper page
- Murray-ZmijewskI, 2008, A complex barcode underlies the heterogeneous response of p53 to stress, Nat. Rev. Mol. Cell Biol., 9, 702, 10.1038/nrm2451 · DOI · Paper page
- Vousden, 2009, Blinded by the Light: The Growing Complexity of p53, Cell, 137, 413, 10.1016/j.cell.2009.04.037 · DOI · Paper page
- Vousden, 2007, p53 in health and disease, Nat. Rev. Mol. Cell. Biol., 8, 275, 10.1038/nrm2147 · DOI · Paper page
- Parant, 2003, Disrupting TP53 in mouse models of human cancers, Hum. Mutat., 21, 321, 10.1002/humu.10186 · DOI
- Royds, 2006, p53 and disease: when the guardian angel fails, Cell Death Differ., 13, 1017, 10.1038/sj.cdd.4401913 · DOI
- Bakalkin, 1995, p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain, Nucleic Acids Res., 23, 362, 10.1093/nar/23.3.362 · DOI · Paper page
- Lee, 1995, p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches, Cell, 81, 1013, 10.1016/S0092-8674(05)80006-6 · DOI · Paper page
- Cain, 2000, The N terminus of p53 regulates its dissociation from DNA, J. Biol. Chem., 275, 39944, 10.1074/jbc.M002509200 · DOI
- Espinosa, 2001, Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment, Mol. Cell, 8, 57, 10.1016/S1097-2765(01)00283-0 · DOI · Paper page
- McKinney, 2002, Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein, Mol. Cell Biol., 22, 6797, 10.1128/MCB.22.19.6797-6808.2002 · DOI
- McKinney, 2004, p53 linear diffusion along DNA requires its C terminus, Mol. Cell, 16, 413, 10.1016/j.molcel.2004.09.032 · DOI · Paper page
- Joerger, 2007, Structural biology of the tumor suppressor p53 and cancer-associated mutants, Adv. Cancer Res., 97, 1, 10.1016/S0065-230X(06)97001-8 · DOI · Paper page
- Okorokov, 2009, Structural biology of the p53 tumour suppressor, Curr. Opin. Struct. Biol., 19, 197, 10.1016/j.sbi.2009.02.003 · DOI
- Kern, 1991, Identification of p53 as a sequence-specific DNA-binding protein, Science, 252, 1708, 10.1126/science.2047879 · DOI · Paper page
- Tokino, 1994, p53 tagged sites from human genomic DNA, Hum. Mol. Genet., 3, 1537, 10.1093/hmg/3.9.1537 · DOI · Paper page
- Harris, 2009, p53 responsive elements in human retrotransposons, Oncogene, 28, 3857, 10.1038/onc.2009.246 · DOI · Paper page
- Kim, 2006, The versatile interactions of p53 with DNA: when flexibility serves specificity, Cell Death Differ., 13, 885, 10.1038/sj.cdd.4401909 · DOI
- Wang, 1995, Interaction of p53 with its consensus DNA-binding site, Mol. Cell Biol., 15, 2157, 10.1128/MCB.15.4.2157 · DOI
- Nicholls, 2002, Biogenesis of p53 involves cotranslational dimerization of monomers and posttranslational dimerization of dimers. Implications on the dominant negative effect, J. Biol. Chem., 277, 12937, 10.1074/jbc.M108815200 · DOI
- Zhao, 2001, Crystal structure of the mouse p53 core DNA-binding domain at 2.7 A resolution, J. Biol. Chem., 276, 12120, 10.1074/jbc.M011644200 · DOI
- Kitayner, 2006, Structural basis of DNA recognition by p53 tetramers, Mol. Cell, 22, 741, 10.1016/j.molcel.2006.05.015 · DOI · Paper page
- Varley, 1997, A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene, Oncogene, 14, 865, 10.1038/sj.onc.1201041 · DOI
- Okorokov, 2006, The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity, EMBO J., 25, 5191, 10.1038/sj.emboj.7601382 · DOI · Paper page
- Tidow, 2007, Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex, Proc. Natl Acad. Sci. USA, 104, 12324, 10.1073/pnas.0705069104 · DOI · Paper page
- Melero, 2011, Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA, Proc. Natl Acad. Sci. USA, 108, 557, 10.1073/pnas.1015520107 · DOI · Paper page
- Hyatt, 2000, Principles and techniques of electron microscopy: biological applications, 543
- Ludtke, 1999, EMAN: semiautomated software for high-resolution single-particle reconstructions, J. Struct. Biol., 128, 82, 10.1006/jsbi.1999.4174 · DOI · Paper page
- Mindell, 2003, Accurate determination of local defocus and specimen tilt in electron microscopy, J. Struct. Biol., 142, 334, 10.1016/S1047-8477(03)00069-8 · DOI · Paper page
- van Heel, 1996, A new generation of the IMAGIC image processing system, J. Struct. Biol., 116, 17, 10.1006/jsbi.1996.0004 · DOI · Paper page
- van Heel, 2000, Single-particle electron cryo-microscopy: towards atomic resolution, Q. Rev. Biophys., 33, 307, 10.1017/S0033583500003644 · DOI · Paper page
- Scheres, 2009, Averaging of electron subtomograms and random conical tilt reconstructions through likelihood optimization, Structure, 17, 1563, 10.1016/j.str.2009.10.009 · DOI
- Pettersen, 2004, UCSF Chimera - A visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 · DOI · Paper page
- Siebert, 2009, UROX 2.0: an interactive tool for fitting atomic models into electron-microscopy reconstructions, Acta Crystallogr. D Biol. Crystallogr., 65, 651, 10.1107/S0907444909008671 · doi:10.1107/s0907444909008671
- Jeffrey, 1995, Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms, Science, 267, 1498, 10.1126/science.7878469 · DOI · Paper page
- Collaborative Computational Project, Number 4, 1994, The CCP4 suite: programs for protein crystallography, Acta Crystallogr. D Biol. Crystallogr., 50, 760, 10.1107/S0907444994003112 · DOI · Paper page
- Milner, 1991, Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation, Cell, 65, 765, 10.1016/0092-8674(91)90384-B · DOI · Paper page
- Hupp, 1994, Allosteric activation of latent p53 tetramers, Curr. Biol., 4, 865, 10.1016/S0960-9822(00)00195-0 · DOI · Paper page
- Kellenberger, 1982, The wrapping phenomenon in air-dried and negatively stained preparations, Ultramicroscopy, 9, 139, 10.1016/0304-3991(82)90236-4 · DOI
- Malecka, 2009, Crystal structure of a p53 core tetramer bound to DNA, Oncogene, 28, 325, 10.1038/onc.2008.400 · DOI
- Jiao, 2001, Dynamic interactions of p53 with DNA in solution by time-lapse atomic force microscopy, J. Mol. Biol., 314, 233, 10.1006/jmbi.2001.5129 · DOI
- Popovych, 2009, Structural basis for cAMP-mediated allosteric control of the catabolite activator protein, Proc. Natl Acad. Sci. USA, 106, 6927, 10.1073/pnas.0900595106 · DOI · Paper page
- Levy, 2008, Molecular basis of halorespiration control by CprK, a CRP-FNR type transcriptional regulator, Mol. Microbiol., 70, 151, 10.1111/j.1365-2958.2008.06399.x · DOI
- Berg, 1981, Diffusion-driven mechanisms of protein translocation on nucleic acids. 1. Models and theory, Biochemistry, 20, 6929, 10.1021/bi00527a028 · DOI · Paper page
- Waterman, 1995, The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding, EMBO J., 14, 512, 10.1002/j.1460-2075.1995.tb07027.x · DOI
- Stenger, 1994, p53 oligomerization and DNA looping are linked with transcriptional activation, EMBO J., 13, 6011, 10.1002/j.1460-2075.1994.tb06947.x · DOI · Paper page
- Jackson, 1998, Synergistic transcriptional activation of the MCK promoter by p53: tetramers link separated DNA response elements by DNA looping, Oncogene, 16, 283, 10.1038/sj.onc.1201491 · DOI
- Harvey, 1995, A mutant p53 transgene accelerates tumour development in hetero zygous but not nulli zygous p53-deficient mice, Nat. Genet., 9, 305, 10.1038/ng0395-305 · DOI
- Liu, 2000, High metastatic potential in mice inheriting a targeted p53 missense mutation, Proc. Natl Acad. Sci. USA, 97, 4174, 10.1073/pnas.97.8.4174 · DOI · Paper page
- de Vries, 2002, Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function, Proc. Natl Acad. Sci. USA, 99, 2948, 10.1073/pnas.052713099 · DOI
- Chène, 2001, The role of tetramerization in p53 function, Oncogene, 20, 2611, 10.1038/sj.onc.1204373 · DOI · Paper page
- Willis, 2004, Mutant p53 exerts a dominant negative effect by pre venting wild-type p53 from binding to the promoter of its target genes, Oncogene, 23, 2330, 10.1038/sj.onc.1207396 · DOI · Paper page
- Kern, 1992, Oncogenic forms of p53 inhibit p53-regulated gene expression, Science, 256, 827, 10.1126/science.1589764 · DOI · Paper page
Cited by
APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
Mohell, N., Alfredsson, J., Fransson, Å., Uustalu, M., Byström, S., Gullbo, J., Hallberg, A., Bykov, V. J. N., Björklund, U., & Wiman, K. G. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.143 · Cited by 183
Krois, A. S., Park, S., Martinez-Yamout, M. A., Dyson, H. J., & Wright, P. E. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00528 · Cited by 14
Metadata
- Authors
- Aramayo, R., Sherman, M. B., Brownless, K., Lurz, R., Okorokov, A. L., & Orlova, E. V.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-07-15
- Volume
- 39
- Issue
- 20
- Pages
- 8960-8971
- ISSN
- 1362-4962
- 0305-1048
- Cited by
- 45
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quaternary structure of the specific p53–DNA complex reveals the mechanism of p53 mutant dominance. https://app.cochat.ai/papers/10.1093/nar/gkr386
- The paper
- Aramayo, R., Sherman, M. B., Brownless, K., Lurz, R., Okorokov, A. L., & Orlova, E. V. (2011). Quaternary structure of the specific p53–DNA complex reveals the mechanism of p53 mutant dominance. Nucleic Acids Research. https://doi.org/10.1093/nar/gkr386
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.